Trial
NCT00066677
Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Fox Chase Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Pancreatic Cancer
Intervention
rhuMAB-VEGF
Why stopped
Stopped accordining to early stopping rule for futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-05